Research Roundup
The most important preeclampsia research studies, explained for you. A team of diverse researchers scour the peer-reviewed research journals to highlight the most important, cutting edge studies. We try to cover basic, molecular, clinical and population sciences, and a wide range of topics such as new findings in preeclampsia diagnoses, treatment, prevention, long-term effects, risk factors and etiology of preeclampsia.
This study suggests that women of different BMI classes might have distinct risk profiles for preeclampsia.
Research is being done to make a medicine that can cure preeclampsia a reality. In this article, researchers asked: what are the candidate medicines being studied currently to prevent or treatment preeclampsia?
This is another study on that journey that shows sFlt1 and PlGF are important proteins in pregnant women’s blood that can tell us about preeclampsia risk.
For this study, researchers asked: what are the barriers to eating a heart healthy diet for women with high blood pressure or a hypertensive disorder of pregnancy?
Two articles were published this quarter that both provide updated statistics about trends in preeclampsia and hypertensive disorders of pregnancy in the United States.
In this study, HMOX1 gene variants were different depending on ancestry, and these genetic changes could be contributing to the racial disparity in hypertensive disorders of pregnancy.
These results highlight two new biomarkers with a possibility of being able to predict timing of onset and subtypes of preeclampsia well before preeclampsia is diagnosed.
This group of studies supports the role of our gut microbiome on preeclampsia risk. Future studies may explore changing the gut microbiome (for example by antibiotics, probiotics, or prebiotics) to help prevent preeclampsia.
This study suggests that eating ultra-processed foods can increase risk for preeclampsia.
Researchers study a new "rule-out" test for preeclampsia which looks at eight different biomarkers.
Research study investigates whether expectant management or early delivery is more beneficial to mom and baby in women with preeclampsia between 34-36 weeks.
Research study finds a clear link between experiencing a hypertensive disorder of pregnancy and risk for cardiovascular disease 30 years later.